Two research teams at Duke University have each won multi-million-dollar federal grants for work toward developing a vaccine for the HIV virus.
Both grants come from the National Institute of Allergy and Infectious Diseases.
The first, for more than $9 million over five years, went to a team led by Dr. Mary Klotman, chair of the Department of Medicine at Duke University School of Medicine. The grant will support two research projects and two facilities that together will aim to develop a safe, effective HIV vaccine using a vector delivery strategy.
The second grant, for more than $11 million over five years, will support an effort led by Dr. Sallie Permar, an assistant professor in the Department of Pediatrics at Duke, and involving researchers at the University of North Carolina and the University of California at Davis.
Permar’s grant funds two projects and three facilities to develop a maternal and infant vaccine approach to eliminate pediatric HIV infections.